A method, and apparatus for the controlled acceleration, and/or retardation of the body's inflammatory response generally comprises a foam pad for insertion substantially into a wound site, a heating, a cooling pad for application over the wound site, a wound drape or sealing enclosure of the foam pad, the heating, and cooling pad at wound site. The foam pad is placed in fluid communication with a vacuum source for promotion of the controlled acceleration or retardation of the body's inflammatory response. The heating, and cooling provision controls the local metabolic function as part of the inflammatory response.

Patent
   7540848
Priority
Apr 02 1999
Filed
Oct 10 2006
Issued
Jun 02 2009
Expiry
May 26 2020

TERM.DISCL.
Extension
56 days
Assg.orig
Entity
Large
81
138
EXPIRED
24. An apparatus for promoting tissue growth comprising:
a pad configured to be placed adjacent a wound site;
a negative pressure source fluidly connected to the pad; and
a cooling element in contact with the pad and having a breathable water layer having fluid channels and apertures between the fluid channels.
12. An apparatus for promoting tissue growth comprising:
a pad configured to be placed adjacent to a wound site;
a negative pressure source fluidly connected to the pad; and
a heating element placed in proximity to the wound site and having a breathable water layer having fluid channels and apertures between the fluid channels.
1. An apparatus for promoting tissue growth comprising:
a pad configured to be placed adjacent a wound site;
a drape having an adhesive for sealing the pad at the wound site and for maintaining a reduced pressure at the wound site;
a negative pressure source fluidly connected to the pad;
a thermal control element placed in proximity to the wound site, the thermal control element having a pair of flexible sheets connected to form at least one fluid channel between the sheets to receive a circulated fluid, the thermal control element further including at least one aperture passing through the sheets to allow transpiration of moisture through the sheets.
2. The apparatus according to claim 1, wherein the at least one fluid channel receives the circulated fluid at a temperature greater than the temperature of the wound site.
3. The apparatus according to claim 2, wherein the circulated fluid is water.
4. The apparatus according to claim 1, wherein the at least one fluid channel receives the circulated fluid at a temperature less than the temperature of the wound site.
5. The apparatus according to claim 4, wherein the circulated fluid is water.
6. The apparatus according to claim 1, wherein the thermal control element is placed in contact with the pad beneath the drape.
7. The apparatus according to claim 1, wherein:
the thermal control element is placed in contact with the pad beneath the drape; and
the at least one fluid channel receives the circulated fluid at a temperature greater than the temperature of the wound site.
8. The apparatus according to claim 1, wherein:
the thermal control element is placed in contact with the pad beneath the drape; and
the at least one fluid channel receives the circulated fluid at a temperature less than the temperature of the wound site.
9. The apparatus according to claim 1, wherein the drape is disposed between the thermal control element and the pad.
10. The apparatus according to claim 1, wherein:
the drape is disposed between the thermal control element and the pad; and
the at least one fluid channel receives the circulated fluid at a temperature greater than the temperature of the wound site.
11. The apparatus according to claim 1, wherein the pair of sheets are connected by RF welds.
13. The apparatus according to claim 12, wherein the heating element is placed in contact with the pad.
14. The apparatus according to claim 12 further comprising a drape having an adhesive for sealing the pad at the wound site and for maintaining a reduced pressure at the wound site.
15. The apparatus according to claim 14, wherein the drape is disposed between the heating element and the pad.
16. The apparatus according to claim 12, wherein the breathable water layer further comprises a first sheet connected to a second sheet to form the fluid channels.
17. The apparatus according to claim 16, wherein the first and second sheets are flexible.
18. The apparatus according to claim 12, wherein the fluid channels are continuous.
19. The apparatus according to claim 12, wherein the fluid channels include an inlet configured for connection to a supply tube and an outlet configured for connection to a drainage tube.
20. The apparatus according to claim 12 further comprising:
a drape having an adhesive for sealing the pad at the wound site and for maintaining a reduced pressure at the wound site;
wherein the breathable water layer further comprises a first sheet connected to a second sheet to form the fluid channels; and
wherein the fluid channels are continuous and include an inlet configured for connection to a supply tube and an outlet configured for connection to a drainage tube.
21. The apparatus according to claim 12, wherein the fluid channels receive a circulating fluid at a temperature greater than the temperature of the wound site.
22. The apparatus according to claim 12, wherein the heating element further comprises a cooling element.
23. The apparatus according to claim 12, wherein:
the heating element further comprises a cooling element; and
the fluid channels receive a circulating fluid at a temperature less than the temperature of the wound site.
25. The apparatus according to claim 24 further comprising a drape having an adhesive for sealing the pad at the wound site and for maintaining a reduced pressure at the wound site.
26. The apparatus according to claim 24, wherein the breathable water layer further comprises a first sheet connected to a second sheet to form the fluid channels.
27. The apparatus according to claim 24, wherein the fluid channels are continuous.
28. The apparatus according to claim 24, wherein the fluid channels include an inlet configured for connection to a supply tube and an outlet configured for connection to a drainage tube.
29. The apparatus according to claim 24 further comprising:
a drape having an adhesive for sealing the pad at the wound site and for maintaining a reduced pressure at the wound site;
wherein the breathable water layer further comprises a first sheet connected to a second sheet to form the fluid channels; and
wherein the fluid channels are continuous and include an inlet configured for connection to a supply tube and an outlet configured for connection to a drainage tube.
30. The apparatus according to claim 24, wherein the fluid channels receive a circulating fluid at a temperature less than the temperature of the wound site.

This is a continuing application of copending U.S. patent application Ser. No. 09/937,937, filed Oct. 2, 2001, which claims the benefit, under 35 U.S.C. 119(e), of U.S. provisional patent application No. 60/127,596, filed Apr. 2, 1999, and the benefit, under 35 U.S.C. § 120, of copending International application No. PCT/US00/08759, filed Mar. 31, 2000; the prior applications are herewith incorporated by reference in their entirety.

1. Field of the Invention

The present invention relates to the healing of wounds. More specifically, the present invention relates to the vacuum assisted closure of wounds wherein localized heating or cooling is used to accelerate or retard the metabolic function of the inflammatory system in order to facilitate wound healing.

2. Description of the Related Art

Wound closure involves the inward migration of epithelial and subcutaneous tissue adjacent the wound. This migration is ordinarily assisted through the inflammatory process, whereby blood flow is increased and various functional cell types are activated. Through the inflammatory process, blood flow through damaged or broken vessels is stopped by capillary level occlusion, whereafter cleanup and rebuilding operations may begin. Unfortunately, this process is hampered when a wound is large or has become infected. In such wounds, a zone of stasis (i.e. an area in which localized swelling of tissue restricts the flow of blood to the tissues) forms near the surface of the wound.

Without sufficient blood flow, the epithelial and subcutaneous tissues surrounding the wound not only receive diminished oxygen and nutrients, but are also less able to successfully fight bacterial infection and thus are less able to naturally close the wound. Until recently, such difficult wounds were addressed only through the use of sutures or staples.

Although still widely practiced and often effective, such mechanical closure techniques suffer a major disadvantage in that they produce tension on the skin tissue adjacent the wound. In particular, the tensile force required in order to achieve closure using sutures or staples causes very high localized stresses at the suture or staple insertion point. These stresses commonly result in the rupture of the tissue at the insertion points, which can eventually cause wound dehiscence and additional tissue loss.

Additionally, some wounds harden and inflame to such a degree due to infection that closure by stapling or suturing is not feasible. Wounds not reparable by suturing or stapling generally require prolonged hospitalization, with its attendant high cost, and major surgical procedures, such as grafts of surrounding tissues. Examples of wounds not readily treatable with staples or suturing include large, deep, open wounds; decubitus ulcers; ulcers resulting from chronic osteomyelitis; and partial thickness burns that subsequently develop into full thickness burns.

As a result of these and other shortcomings of mechanical closure devices, methods and apparatus for draining wounds by applying continuous negative pressures have been developed. When applied over a sufficient area of the wound, such negative pressures have been found to promote the migration toward the wound of epithelial and subcutaneous tissues. In practice, the application to a wound of negative pressure, commonly referred to as vacuum assisted closure (VAC) therapy, typically involves mechanical-like contraction of the wound with simultaneous removal of excess fluid. In this manner, VAC therapy augments the body's natural inflammatory process while alleviating many of the known intrinsic side effects, such as the production of edema caused by increased blood flow absent the necessary vascular structure for proper venous return.

While VAC therapy has been highly successful in the promotion of wound closure, healing many wounds previously thought largely untreatable, some difficulty remains. Because the inflammatory process is very unique to the individual patient, even the addition of VAC therapy does not result in a fast enough response for closure of some wounds, especially when applied during the occlusion and initial cleanup and rebuilding stages. It is therefore a principle object of the present invention to provide a method and apparatus whereby the known VAC therapy modalities are improved through controlled acceleration of the inflammatory response.

Additionally, and again at least partially attributable to the variance between patients, it is possible that a properly initiated inflammatory response may be taken too far, resulting in edema and pain. It is therefore another principle object of the present invention to provide a method and apparatus whereby the known VAC therapy modalities are improved through controlled retardation of the inflammatory response.

In accordance with the foregoing objects, the present invention—a method and apparatus for the controlled acceleration and/or retardation of the body's inflammatory response—generally comprises a foam pad for insertion substantially into a wound site, a heating and cooling pad for application over the wound site and a wound drape for sealing enclosure of the foam pad and the heating and cooling pad at the wound site. According to the invention, the foam pad is placed in fluid communication with a vacuum source for promotion of fluid drainage while warm or cool fluid is circulated through the heating and cooling pad for the controlled acceleration or retardation, respectively, of the metabolic function portion of the body's inflammatory response.

According to the preferred embodiment of the present invention, a heating and cooling provision is added to the previously known VAC therapy to control the local metabolic function as part of the inflammatory response. By providing localized heating in combination with the otherwise ordinary VAC therapy, the overall inflammatory response can be synergistically accelerated to produce rapid capillary occlusion and earlier initiation of the cleanup and rebuilding stages. Likewise, in the event that the attending clinician determines that the inflammatory response has been over-activated, localized cooling may be provided in combination with the VAC therapy to retard the body's inflammatory response without sacrifice of the edema control and other aspects of the otherwise provided VAC therapy.

In the preferred embodiment of the present invention, the heating and cooling pad comprises a flexible and breathable water layer, generally comprising two sheets of RF-weldable material. The two sheets of the pad are RF-welded together in a waffle-like pattern, wherein a plurality of apertures is formed between a plurality of channels. The apertures allow the transpiration of moisture from the patient's skin while the channels allow the circulation, via a supply tube and a drainage tube, of warm or cool water, as required, through the pad for the heating or cooling thereof.

While the heating and cooling pad may be placed inside or outside of the wound drape during the heating aspect of the present invention, it is critical that the heating and cooling pad be placed inside of the wound drape during the cooling aspect of the present invention. In this manner, condensate formation on the interior of the drape, which may cause the drape's adhesive to loosen and ultimately result in loss of vacuum at the wound site, can be minimized. In particular, placing the heating and cooling pad inside the wound drape limits the surrounding moisture content to that existing and generated within the confines of the wound site, which is minimized by the suction aspect of the VAC therapy.

Because the cooling aspect of the present invention should be implemented in this manner and the clinician may indicate the need for cooling at any time after initiation of VAC therapy, the preferred method of the present invention comprises placing the heating and cooling pad beneath the wound drape, adjacent the foam pad and wound site, regardless of whether heating or cooling is initially indicated. Upon placement of the pad, the wound drape is firmly adhered about the supply tube and drainage tube to prevent vacuum leakage.

Finally, many other features, objects and advantages of the present invention will be apparent to those of ordinary skill in the relevant arts, especially in light of the foregoing discussions, the following drawings and exemplary detailed description and the claims appended hereto.

Although the scope of the present invention is much broader than any particular embodiment, a detailed description of the preferred embodiment follows together with illustrative figures, wherein like reference numerals refer to like components, and wherein:

FIG. 1 shows, in partially cut away perspective view, the preferred embodiment of the present invention as applied to a mammalian wound site; and

FIG. 2 shows, in top cross-sectional plan view, the heating and cooling pad of the invention of FIG. 1.

Although those of ordinary skill in the art will readily recognize many alternative embodiments, especially in light of the illustrations provided herein, this detailed description is exemplary of the preferred embodiment of the present invention—a vacuum assisted closure system with heating and cooling provision, the scope of which is limited only by the claims appended hereto.

Referring now to the figures, the present invention 10 is shown to generally comprise a foam pad 11 for insertion substantially into a wound site 12, a heating and cooling pad 13 for application over the wound site 12 and a wound drape 14 for sealing enclosure of the foam pad 11 and the heating and cooling pad 13 at the wound site 12. According to the invention, the foam pad 11 is placed in fluid communication with a vacuum source for promotion of fluid drainage while warm or cool fluid is circulated through the heating and cooling pad 13 for the controlled acceleration or retardation, respectively, of the metabolic function portion of the body's inflammatory response.

According to the preferred embodiment of the present invention, the foam pad 11, wound drape 14 and vacuum source are implemented as known in the prior art, each of which is detailed in U.S. patent application Ser. No. 08/517,901 filed Aug. 22, 1995. By this reference, the full disclosure of U.S. patent application Ser. No. 08/517,901 (“the '901 application”), including the claims and the drawings, is incorporated herein as though now set forth in its entirety. Additionally, such a VAC system is readily commercially available through Kinetic Concepts, Inc. of San Antonio, Tex., U.S.A. and/or its subsidiary companies.

As detailed in the '901 application, the foam pad 11 preferably comprises a highly reticulated, open-cell polyurethane or polyether foam for good permeability of wound fluids while under suction. As also detailed in the '901 application, the foam pad 11 is preferably placed in fluid communication, via a plastic or like material hose 15, with a vacuum source, which preferably comprises a canister safely placed under vacuum through fluid communication, via an interposed hydrophobic membrane filter, with a vacuum pump. Finally, the '901 application also details the wound drape 14, which preferably comprises an elastomeric material at least peripherally covered with a pressure sensitive, acrylic adhesive for sealing application over the wound site 12.

According to the preferred method of the present invention, those components as are described in the '901 application are generally employed as known in the art with the exception that the heating and cooling provision of the present invention is added to control the local metabolic function as part of the inflammatory response. By providing localized heating in combination with the otherwise ordinary VAC therapy, the overall inflammatory response can be synergistically accelerated to produce rapid capillary occlusion and earlier initiation of the cleanup and rebuilding stages. Likewise, in the event that the attending clinician determines that the inflammatory response has been over-activated, localized cooling may be provided in combination with the VAC therapy to retard the body's inflammatory response without sacrifice of the edema control and other aspects of the otherwise provided VAC therapy.

In the preferred embodiment of the present invention, the heating and cooling pad 13 comprises a flexible and breathable water layer 16, generally comprising two sheets 17 (one not shown) of RF-weldable material. The two sheets 17 of the pad are RF-welded together in a waffle-like pattern, wherein a plurality of apertures 19 is formed between a plurality of channels 20. The apertures 19 allow the transpiration of moisture from the patient's skin 21 while the channels 20 allow the circulation, via a supply tube 22 and a drainage tube 23, of warm or cool water, as required, through the pad 13 for the heating or cooling thereof.

While the heating and cooling pad 13 may be placed inside or outside of the wound drape 14 during the heating aspect of the present invention, it is critical that the heating and cooling pad 13 be placed inside of the wound drape 14 during the cooling aspect of the present invention. In this manner, condensate formation on the interior and near the edges of the drape 14, which may cause the drape's adhesive to loosen and ultimately result in loss of vacuum at the wound site 12, can be minimized. In particular, placing the heating and cooling pad 13 inside the wound drape 14 limits the surrounding moisture content to that moisture level existing and generated within the confines of the wound site 12, which is minimized by the suction aspect of the VAC therapy.

Because the cooling aspect of the present invention should be implemented in this manner and the clinician may indicate the need for cooling at any time after initiation of VAC therapy, the preferred method of the present invention comprises placing the heating and cooling pad 13 beneath the wound drape 14, adjacent the foam pad 11 and wound site 12, regardless of whether heating or cooling is initially indicated. Upon placement of the pad 13, the wound drape 14 is firmly adhered about the supply tube 22 and the drainage tube 23 to prevent vacuum leakage.

While the foregoing description is exemplary of the preferred embodiment of the present invention, those of ordinary skill in the relevant arts will recognize the many variations, alterations, modifications, substitutions and the like as are readily possible, especially in light of this description, the accompanying drawings and the claims drawn hereto. For example, those of ordinary skill in the art will recognize that the heating and cooling pad 13 may be constructed in a wide variety of shapes, sizes and internal structures. Such an alternative embodiment may comprise the integration of the heating and cooling pad 13 into a multi-layered version of the wound drape 14. In any case, because the scope of the present invention is much broader than any particular embodiment, the foregoing detailed description should not be construed as a limitation of the present invention, which is limited only by the claims appended hereto.

The present invention is applicable to the wound healing arts.

Johnson, Royce W., Leininger, James R., Dilazzaro, Frank, Fashek, Christopher, Schroeder, Wayne J., Hannigan, Raymond R., Blitz, Jr., Charles I.

Patent Priority Assignee Title
10004881, Jan 21 2009 The Cleveland Clinic Foundation System and method for wound healing
10039868, Apr 28 2004 Smith & Nephew PLC Dressing and apparatus for cleansing the wounds
10058642, Apr 05 2004 Smith & Nephew, Inc Reduced pressure treatment system
10070994, May 22 2012 Smith & Nephew PLC Apparatuses and methods for wound therapy
10105471, Apr 05 2004 Smith & Nephew, Inc Reduced pressure treatment system
10117782, May 24 2012 Smith & Nephew, Inc; University of Massachusetts Devices and methods for treating and closing wounds with negative pressure
10124098, Mar 13 2013 Smith & Nephew, Inc.; University of Massachusetts; Smith & Nephew, Inc Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure
10130520, Jul 16 2012 T J SMITH & NEPHEW LIMITED; Smith & Nephew, Inc Negative pressure wound closure device
10159771, Mar 14 2013 Smith & Nephew PLC Compressible wound fillers and systems and methods of use in treating wounds with negative pressure
10201642, Jan 21 2014 Smith & Nephew PLC Collapsible dressing for negative pressure wound treatment
10207035, May 21 2004 Smith & Nephew, Inc Flexible reduced pressure treatment appliance
10278869, Oct 28 2002 Smith & Nephew PLC Apparatus for aspirating, irrigating and cleansing wounds
10350339, Apr 05 2004 Smith & Nephew, Inc Flexible reduced pressure treatment appliance
10363346, Apr 05 2004 Smith & Nephew, Inc Flexible reduced pressure treatment appliance
10405861, Feb 04 2011 University of Massachusetts Negative pressure wound closure device
10575991, Dec 15 2015 University of Massachusetts Negative pressure wound closure devices and methods
10660992, Oct 21 2013 Smith & Nephew, Inc.; University of Massachusetts Negative pressure wound closure device
10675209, Sep 08 2016 STROUD, KAREN GUTHRIE Fluid therapy device
10702420, May 22 2012 Smith & Nephew PLC Wound closure device
10736787, Apr 02 1999 KCI Licensing, Inc. Negative pressure treatment system with heating and cooling provision
10758424, Apr 28 2004 Smith & Nephew PLC Dressing and apparatus for cleansing the wounds
10758425, Apr 28 2004 Smith & Nephew PLC Negative pressure wound therapy dressing system
10765561, Feb 26 2010 Smith & Nephew, Inc. Systems and methods for using negative pressure wound therapy to manage open abdominal wounds
10814049, Dec 15 2015 University of Massachusetts Negative pressure wound closure devices and methods
10842678, Oct 28 2002 Smith & Nephew PLC Apparatus for aspirating, irrigating and cleansing wounds
10842919, Apr 05 2004 Smith & Nephew, Inc. Reduced pressure treatment system
10850079, Jan 21 2009 The Cleveland Clinic Foundation System and method for wound healing
11007082, Jul 23 2014 Innovative Therapies, LLC Foam laminate dressing
11013910, Feb 06 2018 Adlore, Inc. Devices, methods, and systems for the treatment and/or monitoring of damaged tissue
11083631, Jul 16 2012 University of Massachusetts; Smith & Nephew, Inc. Negative pressure wound closure device
11097044, Mar 14 2013 Smith & Nephew PLC Compressible wound fillers and systems and methods of use in treating wounds with negative pressure
11166726, Feb 04 2011 University of Massachusetts Negative pressure wound closure device
11241337, May 24 2012 Smith & Nephew, Inc.; University of Massachusetts Devices and methods for treating and closing wounds with negative pressure
11338128, Aug 28 2019 Adlore, Inc. Apparatuses, systems, and methods for the treatment of damaged tissue
11419767, Mar 13 2013 University of Massachusetts; Smith and Nephew, Inc. Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure
11439539, Apr 29 2015 University of Massachusetts; Smith & Nephew Inc.; SMITH & NEPHEW INC Negative pressure wound closure device
11471586, Dec 15 2015 University of Massachusetts Negative pressure wound closure devices and methods
11484443, Feb 26 2010 Smith & Nephew, Inc. Systems and methods for using negative pressure wound therapy to manage open abdominal wounds
11559439, May 22 2012 Smith & Nephew PLC Wound closure device
11564843, Jul 16 2012 University of Massachusetts; Smith & Nephew, Inc. Negative pressure wound closure device
11614170, Jul 29 2015 Innovative Therapies, LLC Wound therapy device pressure monitoring and control system
11730874, Apr 05 2004 Smith & Nephew, Inc. Reduced pressure treatment appliance
7794450, Oct 28 2003 Smith & Nephew PLC Wound cleansing apparatus with heat
8052624, Oct 29 2008 Stryker Corporation Negative pressure, thermal energy transfer device that also provides positive pressure to the patient
8066243, Jan 08 2010 Innovative Therapies, LLC Adapter for portable negative pressure wound therapy device
8348910, Apr 28 2004 Smith & Nephew PLC Apparatus for cleansing wounds with means for supply of thermal energy to the therapy fluid
8372022, Apr 02 1999 KCI Licensing, Inc. Negative pressure treatment system with heating and cooling provision
8398614, Oct 28 2002 Smith & Nephew PLC Apparatus for aspirating, irrigating and cleansing wounds
8444613, Jul 14 2009 Innovative Therapies, LLC Pump leak monitor for negative pressure wound therapy
8449509, Apr 05 2004 Smith & Nephew, Inc Flexible reduced pressure treatment appliance
8460355, Apr 05 2007 Stryker Corporation Negative/positive pressure, thermal energy therapy device
8529548, Apr 27 2004 Smith & Nephew PLC Wound treatment apparatus and method
8551061, Jul 02 2007 Smith & Nephew PLC Wound treatment apparatus with exudate volume reduction by heat
8834451, Oct 28 2002 Smith & Nephew PLC In-situ wound cleansing apparatus
8845619, Apr 27 2004 Smith & Nephew PLC Wound treatment apparatus and method
8882687, Apr 02 1999 KCI Licensing, Inc. Negative pressure treatment system with heating and cooling provision
8926592, Oct 28 2003 Smith & Nephew PLC Wound cleansing apparatus with heat
9050399, Jul 02 2007 Smith & Nephew PLC Wound treatment apparatus with exudate volume reduction by heat
9198801, Apr 05 2004 Smith & Nephew, Inc Flexible reduced pressure treatment appliance
9205001, Oct 28 2002 Smith & Nephew PLC Apparatus for aspirating, irrigating and cleansing wounds
9226737, Feb 04 2011 University of Massachusetts Negative pressure wound closure device
9289542, Oct 28 2003 Smith & Nephew PLC Wound cleansing apparatus
9301742, Feb 04 2011 University of Massachusetts Negative pressure wound closure device
9421132, Feb 04 2011 University of Massachusetts Negative pressure wound closure device
9511177, Apr 27 2005 Smith & Nephew PLC Wound treatment apparatus and method
9545463, Apr 27 2005 Smith & Nephew PLC Wound treatment apparatus and method
9616208, Oct 28 2003 Smith & Nephew PLC Wound cleansing apparatus
9687647, Jan 21 2009 The Cleveland Clinic Foundation System and method for wound healing
9724243, Apr 02 1999 KCI Licensing, Inc. Negative pressure treatment system with heating and cooling provision
9844472, May 22 2012 Smith & Nephew, Inc; University of Massachusetts Wound closure device
9844473, Oct 28 2002 Smith & Nephew PLC Apparatus for aspirating, irrigating and cleansing wounds
9844474, Oct 28 2002 Smith & Nephew PLC Apparatus for aspirating, irrigating and cleansing wounds
9950100, Apr 28 2004 Smith & Nephew PLC Negative pressure wound therapy dressing system
9956327, Jul 02 2007 Smith & Nephew PLC Wound treatment apparatus with exudate volume reduction by heat
9962295, Jul 16 2012 T J SMITH & NEPHEW LIMITED; Smith & Nephew, Inc Negative pressure wound closure device
D680655, Oct 12 2010 VENOUS HEALTH SYSTEMS, INC Constellation of chambers for distributing pneumatic pressure
D682437, Dec 13 2010 VENOUS HEALTH SYSTEMS, INC Constellation of chambers for distributing pneumatic pressure
D682438, Dec 13 2010 VENOUS HEALTH SYSTEMS, INC Constellation of chambers for distributing pneumatic pressure
D682439, Dec 13 2010 VENOUS HEALTH SYSTEMS, INC Constellation of chambers for distributing pneumatic pressure
D690021, Dec 13 2010 VENOUS HEALTH SYSTEMS, INC Constellation of chambers for distributing pneumatic pressure
D690824, Dec 13 2010 VENOUS HEALTH SYSTEMS, INC Constellation of chambers for distributing pneumatic pressure
Patent Priority Assignee Title
1355846,
2547758,
2632443,
2682873,
2910763,
2969057,
3066672,
3367332,
3520300,
3568675,
3648692,
3682180,
3826254,
4080970, Nov 17 1976 Post-operative combination dressing and internal drain tube with external shield and tube connector
4096853, Jun 21 1975 Hoechst Aktiengesellschaft Device for the introduction of contrast medium into an anus praeter
4139004, Feb 17 1977 Bandage apparatus for treating burns
4165748, Nov 07 1977 Catheter tube holder
4184510, Mar 15 1977 Fibra-Sonics, Inc. Valued device for controlling vacuum in surgery
4233969, Nov 11 1976 ANSONIA NOMINEES LIMITED, 1 LOVE LANE, LONDON, EC2; ENGLISH ASSOCIATION OF AMERICAN THE, BOND AND SHARE HOLDERS LIMITED, 4 FORE STREET, LONDON EC2; FOSTER AND BRAITHWAITE, 22 AUSTIN FRIARS, LONDON, EC2; JESSEL GROUP THE, 30 REIGATE HILL, REIGATE, SURREY RH2 OAR; STRABUL NOMINEES LIMITED, 3 MOORGATE PLACE, LONDON, EC2; LLOYDS BANK BRANCHES NOMINEES LIMITED, 111 OLD BROAD STREET, LONDON, EC2 Wound dressing materials
4245630, Oct 08 1976 T. J. Smith & Nephew, Ltd. Tearable composite strip of materials
4256109, Jul 10 1978 Allegiance Corporation Shut off valve for medical suction apparatus
4261363, Nov 09 1979 C R BARD, INC , A CORP OF NJ Retention clips for body fluid drains
4275721, Nov 28 1978 Procter & Gamble Hygien Aktiebolag Vein catheter bandage
4284079, Jun 28 1979 Method for applying a male incontinence device
4297995, Jun 03 1980 KEY PHARMACEUTICALS, INC Bandage containing attachment post
4333468, Aug 18 1980 Mesentery tube holder apparatus
4373519, Jun 26 1981 Minnesota Mining and Manufacturing Company Composite wound dressing
4382441, Dec 06 1978 Device for treating tissues, for example skin
4392853, Mar 16 1981 Sterile assembly for protecting and fastening an indwelling device
4392858, Jul 16 1981 Sherwood Services AG; TYCO GROUP S A R L Wound drainage device
4419097, Jul 31 1981 Rexar Industries, Inc. Attachment for catheter tube
4465485,
4475909, May 06 1982 Male urinary device and method for applying the device
4480638, Mar 11 1980 Cushion for holding an element of grafted skin
4525166, Nov 21 1981 B BRAUN-SSC AG Rolled flexible medical suction drainage device
4525374, Feb 27 1984 MANRESA, INC Treating hydrophobic filters to render them hydrophilic
4540412, Jul 14 1983 The Kendall Company Device for moist heat therapy
4543100, Nov 01 1983 Catheter and drain tube retainer
4548202, Jun 20 1983 Ethicon, Inc. Mesh tissue fasteners
4551139, Feb 08 1982 Marion Laboratories, Inc. Method and apparatus for burn wound treatment
4569348, Feb 22 1980 VELCRO INDUSTRIES B V Catheter tube holder strap
4608041, Oct 14 1981 Device for treatment of wounds in body tissue of patients by exposure to jets of gas
4640688, Aug 23 1985 Mentor Corporation Urine collection catheter
4655754, Nov 09 1984 Stryker Corporation Vacuum wound drainage system and lipids baffle therefor
4664662, Aug 02 1984 Smith and Nephew Associated Companies plc Wound dressing
4710165, Sep 16 1985 SURGIDYNE, INC Wearable, variable rate suction/collection device
4733659, Jan 17 1986 Seton Company Foam bandage
4743232, Oct 06 1986 The Clinipad Corporation Package assembly for plastic film bandage
4758220, Sep 26 1985 ALCON MANUFACTURING, LTD Surgical cassette proximity sensing and latching apparatus
4787888, Jun 01 1987 University of Connecticut Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a)
4826494, Nov 09 1984 Stryker Corporation Vacuum wound drainage system
4838883, Mar 07 1986 Nissho Corporation Urine-collecting device
4840187, Sep 11 1986 BARD LIMITED, PENNYWELL INDUSTRIAL ESTATE, SUNDERLAND SR4 9EW, ENGLAND Sheath applicator
4863449, Jul 06 1987 Hollister Incorporated Adhesive-lined elastic condom cathether
4872450, Aug 17 1984 Wound dressing and method of forming same
4878901, Dec 07 1987 Condom catheter, a urethral catheter for the prevention of ascending infections
4897081, May 25 1984 TMCA FOUNDATION INC Percutaneous access device
4906233, May 29 1986 Terumo Kabushiki Kaisha Method of securing a catheter body to a human skin surface
4906240, Feb 01 1988 Innovative Technologies Limited Adhesive-faced porous absorbent sheet and method of making same
4919654, Aug 03 1988 KALT MEDICAL CORPORATION, A CORP OF FLORIDA IV clamp with membrane
4941882, Mar 14 1987 Smith and Nephew Associated Companies, p.l.c. Adhesive dressing for retaining a cannula on the skin
4953565, Nov 26 1986 Shunro Tachibana Endermic application kits for external medicines
4969880, Apr 03 1989 KCI Licensing, Inc Wound dressing and treatment method
4985019, Mar 11 1988 Warsaw Orthopedic, Inc X-ray marker
5037397, Dec 27 1985 Medical Distributors, Inc. Universal clamp
5086170, Jan 16 1989 Roussel Uclaf Process for the preparation of azabicyclo compounds
5086771, Sep 05 1991 Gentherm Medical, LLC Configured pad for therapeutic cooling effect
5092858, Mar 20 1990 Becton, Dickinson and Company Liquid gelling agent distributor device
5100396, Apr 03 1989 KCI Licensing, Inc Fluidic connection system and method
5134994, Feb 12 1990 SAY, SAMUEL L AND BETTY JANE SAY, TRUSTEES OF THE SAY FAMILY TRUST DATED DECEMBER 2, 1995 Field aspirator in a soft pack with externally mounted container
5149331, May 03 1991 Ariel, Ferdman Method and device for wound closure
5167613, Mar 23 1992 The Kendall Company Composite vented wound dressing
5176663, Dec 02 1987 Principal AB; PHARMARK INNOVATIONS, LTD ; INNOVATIVE THERAPIES, INC Dressing having pad with compressibility limiting elements
5215522, Jul 23 1984 CITIBANK, N A Single use medical aspirating device and method
5232453, Jul 14 1989 CONVATEC TECHNOLOGIES INC Catheter holder
5261893, Apr 03 1989 KCI Licensing, Inc Fastening system and method
5278100, Nov 08 1991 Micron Technology, Inc. Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers
5279550, Dec 19 1991 Gish Biomedical, Inc. Orthopedic autotransfusion system
5298015, Jul 11 1989 Nippon Zeon Co., Ltd. Wound dressing having a porous structure
5342376, May 03 1993 Ethicon, Inc Inserting device for a barbed tissue connector
5344415, Jun 15 1993 DeRoyal Industries, Inc. Sterile system for dressing vascular access site
5358494, Jul 11 1989 Principal AB; PHARMARK INNOVATIONS, LTD Irrigation dressing
5437622, Apr 29 1992 Laboratoire Hydrex (SA) Transparent adhesive dressing with reinforced starter cuts
5437651, Sep 01 1993 Edwards Lifesciences Corporation Medical suction apparatus
5527293, May 14 1901 KCI Licensing, Inc Fastening system and method
5549584, Feb 14 1994 Smith & Nephew, Inc Apparatus for removing fluid from a wound
5556375, Jun 16 1994 Hercules Incorporated Wound dressing having a fenestrated base layer
5607388, Jun 16 1994 Hercules Incorporated Multi-purpose wound dressing
5636643, Nov 14 1991 WAKE FOREST UNIVERSITY HEALTH SCIENCES Wound treatment employing reduced pressure
5645081, Nov 14 1991 WAKE FOREST UNIVERSITY HEALTH SCIENCES Method of treating tissue damage and apparatus for same
6071267, Feb 06 1998 KCI Licensing, Inc Medical patient fluid management interface system and method
6135116, Jul 28 1997 KCI Licensing, Inc Therapeutic method for treating ulcers
6241747, May 03 1993 Ethicon, Inc Barbed Bodily tissue connector
6287316, Mar 26 1999 Ethicon, Inc Knitted surgical mesh
6345623, Sep 12 1997 KCI Licensing, Inc Surgical drape and suction head for wound treatment
6398767, May 27 1997 KCI Medical Resources Process and device for application of active substances to a wound surface area
6458109, Aug 07 1998 KCI Licensing, Inc Wound treatment apparatus
6488643, Oct 08 1998 Huntleigh Technology Limited Wound healing foot wrap
6493568, Jul 19 1994 Huntleigh Technology Limited Patient interface system
6520982, Jun 08 2000 KCI Licensing, Inc.; KCI Licensing, Inc Localized liquid therapy and thermotherapy device
6553998, Sep 12 1997 KCI Licensing, Inc Surgical drape and suction head for wound treatment
6814079, Sep 12 1997 KCI Licensing, Inc Surgical drape and suction head for wound treatment
7144390, Apr 02 1999 Kinetic Concepts, Inc Negative pressure treatment system with heating and cooling provision
20020077661,
20020115951,
20020120185,
20020143286,
AU550575,
AU745271,
AU755496,
CA2005436,
DE2640413,
DE29504378,
DE4306478,
EP100148,
EP117632,
EP161865,
EP358302,
EP1018967,
GB2195255,
GB2197789,
GB2220357,
GB2235877,
GB2329127,
GB2333965,
GB692578,
JP4129536,
SG71559,
WO9309727,
WO7653,
WO8002182,
WO8704626,
WO9010424,
WO9420041,
WO9605873,
WO9718007,
WO9823236,
WO9913793,
/////////////////////////////////////////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Sep 19 2001Kinetic Concepts, IncKCI Licensing, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0195260413 pdf
Sep 10 2003SCHROEDER, WAYNE J Kinetic Concepts, IncNUNC PRO TUNC ASSIGNMENT SEE DOCUMENT FOR DETAILS 0212790001 pdf
Sep 11 2003JOHNSON, ROYCE W Kinetic Concepts, IncNUNC PRO TUNC ASSIGNMENT SEE DOCUMENT FOR DETAILS 0212790001 pdf
Sep 11 2003HANNIGAN, RAYMOND R Kinetic Concepts, IncNUNC PRO TUNC ASSIGNMENT SEE DOCUMENT FOR DETAILS 0212790001 pdf
Sep 12 2003FASHEK, CHRISTOPHERKinetic Concepts, IncNUNC PRO TUNC ASSIGNMENT SEE DOCUMENT FOR DETAILS 0212790001 pdf
Sep 12 2003DILAZZARO, FRANKKinetic Concepts, IncNUNC PRO TUNC ASSIGNMENT SEE DOCUMENT FOR DETAILS 0212790001 pdf
Sep 12 2003BLITZ, CHARLES I , JR Kinetic Concepts, IncNUNC PRO TUNC ASSIGNMENT SEE DOCUMENT FOR DETAILS 0212790001 pdf
Sep 22 2003LEININGER, JAMES R Kinetic Concepts, IncNUNC PRO TUNC ASSIGNMENT SEE DOCUMENT FOR DETAILS 0212790001 pdf
Oct 10 2006KCI Licensing, Inc.(assignment on the face of the patent)
Jul 31 2007KCI Licensing, IncCITIBANK, N A , AS ADMINISTRATIVE AGENTSECURITY AGREEMENT0196400163 pdf
Jul 31 2007Kinetic Concepts, IncCITIBANK, N A , AS ADMINISTRATIVE AGENTSECURITY AGREEMENT0196400163 pdf
Jul 31 2007KCI USA, INC CITIBANK, N A , AS ADMINISTRATIVE AGENTSECURITY AGREEMENT0196400163 pdf
Jul 31 2007KCI HOLDING COMPANY, INC CITIBANK, N A , AS ADMINISTRATIVE AGENTSECURITY AGREEMENT0196400163 pdf
Jul 31 2007KCI INTERNATIONAL, INCCITIBANK, N A , AS ADMINISTRATIVE AGENTSECURITY AGREEMENT0196400163 pdf
May 15 2008CITIBANK, N A KCI INTERNATIONAL, INCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0210180130 pdf
May 15 2008CITIBANK, N A Kinetic Concepts, IncRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0210180130 pdf
May 15 2008CITIBANK, N A KCI USA, INC RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0210180130 pdf
May 15 2008CITIBANK, N A KCI HOLDING COMPANY, INC RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0210180130 pdf
May 15 2008CITIBANK, N A KCI Licensing, IncRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0210180130 pdf
May 19 2008Kinetic Concepts, IncBANK OF AMERICA, N A SECURITY AGREEMENT0210060847 pdf
May 19 2008KCI Licensing, IncBANK OF AMERICA, N A SECURITY AGREEMENT0210060847 pdf
Jan 07 2011BANK OF AMERICA, N A , AS ADMINISTRATIVE AGENTLifeCell CorporationTERMINATION OF SECURITY INTEREST IN PATENTS0255990904 pdf
Jan 07 2011BANK OF AMERICA, N A , AS ADMINISTRATIVE AGENTKinetic Concepts, IncTERMINATION OF SECURITY INTEREST IN PATENTS0255990904 pdf
Jan 07 2011BANK OF AMERICA, N A , AS ADMINISTRATIVE AGENTKCI Licensing, IncTERMINATION OF SECURITY INTEREST IN PATENTS0255990904 pdf
Nov 04 2011LifeCell CorporationBANK OF AMERICA, N A , AS COLLATERAL AGENTSECURITY AGREEMENT0271850174 pdf
Nov 04 2011Technimotion, LLCBANK OF AMERICA, N A , AS COLLATERAL AGENTSECURITY AGREEMENT0271850174 pdf
Nov 04 2011KCI Licensing, IncWILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTSECURITY AGREEMENT0271940447 pdf
Nov 04 2011LifeCell CorporationWILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTSECURITY AGREEMENT0271940447 pdf
Nov 04 2011Technimotion, LLCWILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTSECURITY AGREEMENT0271940447 pdf
Nov 04 2011KCI Licensing, IncBANK OF AMERICA, N A , AS COLLATERAL AGENTSECURITY AGREEMENT0271850174 pdf
Sep 20 2016LifeCell CorporationWILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTSECOND LIEN SECURITY AGREEMENT0400980268 pdf
Sep 20 2016KCI Licensing, IncWILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTSECOND LIEN SECURITY AGREEMENT0400980268 pdf
Sep 20 2016KCI USA, INC WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTSECOND LIEN SECURITY AGREEMENT0400980268 pdf
Sep 20 2016WILMINGTON TRUSTKCI Licensing, IncRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0400980200 pdf
Sep 20 2016WILMINGTON TRUSTTechnimotion, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0400980200 pdf
Sep 20 2016WILMINGTON TRUSTKinetic Concepts, IncRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0400980200 pdf
Sep 20 2016WILMINGTON TRUSTLifeCell CorporationRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0400980200 pdf
Oct 06 2016LifeCell CorporationWILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTLIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0402910237 pdf
Oct 06 2016KCI USA, INC WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTLIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0402910237 pdf
Oct 06 2016KCI Licensing, IncWILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENTLIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0402910237 pdf
Feb 03 2017BANK OF AMERICA, N A , AS COLLATERAL AGENTTECHNIMOTION, LLC, A DELAWARE LIMITED LIABILITY COMPANY, AS GRANTORRELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY0413950044 pdf
Feb 03 2017BANK OF AMERICA, N A , AS COLLATERAL AGENTKCI LICENSING, INC , AS GRANTORRELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY0413950044 pdf
Feb 03 2017BANK OF AMERICA, N A , AS COLLATERAL AGENTSYSTAGENIX WOUND MANAGEMENT US , INC , A DELAWARE CORPORATION, AS GRANTORRELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY0413950044 pdf
Oct 11 2019WILMINGTON TRUST, NATIONAL ASSOCIATIONKCI USA, INC RELEASE OF SECURITY INTEREST IN PATENTS0509660547 pdf
Oct 11 2019WILMINGTON TRUST, NATIONAL ASSOCIATIONKCI Licensing, IncRELEASE OF SECURITY INTEREST IN PATENTS0509660547 pdf
Date Maintenance Fee Events
Jul 12 2010ASPN: Payor Number Assigned.
Oct 01 2012M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Nov 17 2016M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Jan 18 2021REM: Maintenance Fee Reminder Mailed.
Jul 05 2021EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Jun 02 20124 years fee payment window open
Dec 02 20126 months grace period start (w surcharge)
Jun 02 2013patent expiry (for year 4)
Jun 02 20152 years to revive unintentionally abandoned end. (for year 4)
Jun 02 20168 years fee payment window open
Dec 02 20166 months grace period start (w surcharge)
Jun 02 2017patent expiry (for year 8)
Jun 02 20192 years to revive unintentionally abandoned end. (for year 8)
Jun 02 202012 years fee payment window open
Dec 02 20206 months grace period start (w surcharge)
Jun 02 2021patent expiry (for year 12)
Jun 02 20232 years to revive unintentionally abandoned end. (for year 12)